Report Provides an Update on the 340B Drug Pricing Program

Aaron Vandervelde provides an update on topics including Medicare Part B outpatient drug spend of 340B hospitals, growth in the program, and reimbursement from Medicare for Part B oncology drugs.

Read the article.

Read the white paper update.